18 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
1
Identifying Interactions that Determine Fragment Binding at Protein Hotspots.

Cambridge Crystallographic Data Centre
32
Design, synthesis and biological evaluation of imidazo[2,1-b]thiazole and benzo[d]imidazo[2,1-b]thiazole derivatives as Mycobacterium tuberculosis pantothenate synthetase inhibitors.

Birla Institute of Technology
1
Synthesis, in vitro antimycobacterial evaluation and docking studies of some new 5,6,7,8-tetrahydropyrido[4',3':4,5]thieno[2,3-d]pyrimidin-4(3H)-one schiff bases.

University College of Pharmaceutical Sciences
29
Development of novel tetrahydrothieno[2,3-c]pyridine-3-carboxamide based Mycobacterium tuberculosis pantothenate synthetase inhibitors: molecular hybridization from known antimycobacterial leads.

Birla Institute of Technology
5
Reaction intermediate analogues as bisubstrate inhibitors of pantothenate synthetase.

Soochow University
8
Development of 3-phenyl-4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridine derivatives as novel Mycobacterium tuberculosis pantothenate synthetase inhibitors.

Birla Institute of Technology
17
ATP-binding site of bacterial enzymes as a target for antibacterial drug design.

University of Ljubljana
15
5-tert-butyl-N-pyrazol-4-yl-4,5,6,7-tetrahydrobenzo[d]isoxazole-3-carboxamide derivatives as novel potent inhibitors of Mycobacterium tuberculosis pantothenate synthetase: initiating a quest for new antitubercular drugs.

University of Illinois At Chicago
3
A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.

Peking Union Medical College
10
Fragment-to-Lead Medicinal Chemistry Publications in 2022.

Astex Pharmaceuticals
7
Comprehensive coverage on anti-mycobacterial endeavour reported during 2022.

L. M. College of Pharmacy
2
Emerging impact of triazoles as anti-tubercular agent.

Barauni (A Constituent Unit of Lalit Narayan Mithila University)
33
Identification and development of 2-methylimidazo[1,2-a]pyridine-3-carboxamides as Mycobacterium tuberculosis pantothenate synthetase inhibitors.

Birla Institute of Technology & Science-Pilani
3
Triazole derivatives and their anti-tubercular activity.

Wuhan University of Science and Technology
2
Recent advances of pyrazole-containing derivatives as anti-tubercular agents.

Wuhan University of Science and Technology
165
Substituted pyrrolo[2,3-b]pyridines as MLK inhibitors

The University of Rochester
126
HPK1 INHIBITOR AND MEDICAL USE THEREOF

Betta Pharmaceuticals
1
Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro.

Janssen Research Foundation